EUVIMEDEUVIMED entdecken
Crossref

122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS

A. Zoref‐Lorenz, E. J. Cahn, E. Mou, G. Cholack, Y. Wang, M. Maurer, A. L. Feldman, B. J. Negaard, R. Mwangi, G. Itchaki, G. Nowakowski, T. M. Habermann und 6 weitere

Hematological Oncology · 2025-06 · 43 (S3)

DOI: 10.1002/hon.70093_122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 16.06.2025. Verfasst von A. Zoref‐Lorenz und 17 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zoref‐Lorenz, A., Cahn, E. J., Mou, E., Cholack, G., Wang, Y., Maurer, M., Feldman, A. L., Negaard, B. J., Mwangi, R., Itchaki, G., Nowakowski, G., Habermann, T. M., Link, B. K., Ansell, S. M., Novak, A. J., Witzig, T. E., Cerhan, J. R., & Jordan, M. (2025). 122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS. Hematological Oncology, 43(S3). https://doi.org/10.1002/hon.70093_122

Vancouver

Zoref‐Lorenz A, Cahn EJ, Mou E, Cholack G, Wang Y, Maurer M, et al. 122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS. Hematological Oncology. 2025;43(S3). doi:10.1002/hon.70093_122

BibTeX
@article{ZorefLorenz2025,
  author = {Zoref‐Lorenz, A. and Cahn, E. J. and Mou, E. and Cholack, G. and Wang, Y. and Maurer, M. and Feldman, A. L. and Negaard, B. J. and Mwangi, R. and Itchaki, G. and Nowakowski, G. and Habermann, T. M. and Link, B. K. and Ansell, S. M. and Novak, A. J. and Witzig, T. E. and Cerhan, J. R. and Jordan, M.},
  title = {122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS},
  journal = {Hematological Oncology},
  year = {2025},
  volume = {43},
  number = {S3},
  doi = {10.1002/hon.70093_122}
}
Kostenlos starten →